Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Atrial Fibrillation | 40 | 2024 | 5033 | 3.850 |
Why?
|
Electrocardiography, Ambulatory | 2 | 2021 | 585 | 0.810 |
Why?
|
Stroke | 12 | 2024 | 9975 | 0.730 |
Why?
|
Venous Thromboembolism | 2 | 2021 | 1670 | 0.630 |
Why?
|
Anticoagulants | 11 | 2024 | 4599 | 0.580 |
Why?
|
Vitamin K | 2 | 2018 | 295 | 0.570 |
Why?
|
Atrial Appendage | 2 | 2023 | 282 | 0.550 |
Why?
|
Warfarin | 4 | 2023 | 1497 | 0.540 |
Why?
|
Hypotension, Orthostatic | 1 | 2017 | 255 | 0.490 |
Why?
|
Blood Proteins | 1 | 2019 | 1125 | 0.470 |
Why?
|
Patient Care Management | 1 | 2016 | 306 | 0.450 |
Why?
|
Metabolomics | 3 | 2023 | 1487 | 0.450 |
Why?
|
Cardiovascular Diseases | 4 | 2024 | 15142 | 0.380 |
Why?
|
Fibrinolytic Agents | 1 | 2020 | 2159 | 0.360 |
Why?
|
Veterans | 1 | 2024 | 2519 | 0.360 |
Why?
|
Forecasting | 1 | 2019 | 2950 | 0.350 |
Why?
|
Heart Diseases | 1 | 2022 | 2789 | 0.350 |
Why?
|
Risk Factors | 24 | 2024 | 72252 | 0.340 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2020 | 1462 | 0.340 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2020 | 1458 | 0.330 |
Why?
|
Dementia | 1 | 2022 | 2518 | 0.320 |
Why?
|
Heart Failure | 7 | 2023 | 10896 | 0.320 |
Why?
|
Incidence | 14 | 2024 | 20948 | 0.310 |
Why?
|
Cerebral Hemorrhage | 1 | 2018 | 2647 | 0.290 |
Why?
|
Brain Ischemia | 2 | 2020 | 3264 | 0.280 |
Why?
|
Risk Assessment | 8 | 2021 | 23327 | 0.270 |
Why?
|
Medicare | 8 | 2024 | 6565 | 0.270 |
Why?
|
Aged | 28 | 2024 | 163178 | 0.270 |
Why?
|
Proteomics | 1 | 2019 | 3639 | 0.270 |
Why?
|
Humans | 50 | 2024 | 743811 | 0.230 |
Why?
|
Cardiomyopathy, Alcoholic | 1 | 2023 | 6 | 0.230 |
Why?
|
Alzheimer Disease | 1 | 2024 | 8035 | 0.220 |
Why?
|
Genome-Wide Association Study | 2 | 2019 | 12259 | 0.220 |
Why?
|
Longitudinal Studies | 9 | 2023 | 13980 | 0.210 |
Why?
|
Hemorrhage | 1 | 2014 | 3458 | 0.210 |
Why?
|
Female | 33 | 2023 | 380020 | 0.210 |
Why?
|
Male | 32 | 2023 | 349776 | 0.210 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 3255 | 0.200 |
Why?
|
United States | 11 | 2024 | 69859 | 0.200 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2023 | 362 | 0.180 |
Why?
|
Heart Rate | 3 | 2021 | 4091 | 0.180 |
Why?
|
Antihypertensive Agents | 3 | 2023 | 2047 | 0.170 |
Why?
|
Prognosis | 8 | 2024 | 29052 | 0.170 |
Why?
|
Cardiomyopathy, Dilated | 2 | 2023 | 851 | 0.170 |
Why?
|
Stroke Volume | 3 | 2023 | 5002 | 0.170 |
Why?
|
Uncertainty | 1 | 2024 | 735 | 0.170 |
Why?
|
Frail Elderly | 1 | 2023 | 693 | 0.160 |
Why?
|
Renal Insufficiency, Chronic | 3 | 2023 | 2200 | 0.150 |
Why?
|
Atrial Function | 1 | 2017 | 107 | 0.150 |
Why?
|
Administration, Oral | 2 | 2022 | 3912 | 0.140 |
Why?
|
Age Factors | 6 | 2020 | 18355 | 0.140 |
Why?
|
Sex Factors | 4 | 2019 | 10394 | 0.140 |
Why?
|
Aging | 1 | 2014 | 8655 | 0.130 |
Why?
|
Quality of Life | 1 | 2016 | 12788 | 0.130 |
Why?
|
Heart Atria | 1 | 2021 | 1357 | 0.130 |
Why?
|
Aged, 80 and over | 10 | 2023 | 57744 | 0.120 |
Why?
|
Metabolome | 1 | 2021 | 894 | 0.120 |
Why?
|
Vasodilation | 1 | 2018 | 944 | 0.120 |
Why?
|
Middle Aged | 20 | 2023 | 213241 | 0.120 |
Why?
|
Comorbidity | 3 | 2024 | 10380 | 0.120 |
Why?
|
Drug Utilization | 1 | 2020 | 1183 | 0.120 |
Why?
|
Blood Pressure Determination | 1 | 2017 | 633 | 0.120 |
Why?
|
Drug Interactions | 1 | 2018 | 1460 | 0.110 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2021 | 1524 | 0.110 |
Why?
|
Respiratory Insufficiency | 1 | 2021 | 1199 | 0.110 |
Why?
|
Chromatography, Liquid | 1 | 2016 | 975 | 0.110 |
Why?
|
Hypertension | 3 | 2023 | 8480 | 0.110 |
Why?
|
Retrospective Studies | 7 | 2023 | 77410 | 0.110 |
Why?
|
Diabetes Mellitus | 2 | 2023 | 5752 | 0.110 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2023 | 2074 | 0.100 |
Why?
|
Telomere | 1 | 2017 | 910 | 0.100 |
Why?
|
Heart Conduction System | 1 | 2017 | 1047 | 0.100 |
Why?
|
Proteome | 1 | 2021 | 1794 | 0.100 |
Why?
|
Diabetes Complications | 1 | 2018 | 1360 | 0.090 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2023 | 3070 | 0.090 |
Why?
|
Drug Prescriptions | 1 | 2020 | 1636 | 0.090 |
Why?
|
Time Factors | 4 | 2021 | 40038 | 0.090 |
Why?
|
Europe | 1 | 2016 | 3336 | 0.090 |
Why?
|
Follow-Up Studies | 4 | 2021 | 39001 | 0.090 |
Why?
|
Treatment Outcome | 3 | 2023 | 63042 | 0.090 |
Why?
|
Leukocytes | 1 | 2017 | 2044 | 0.090 |
Why?
|
Mass Spectrometry | 1 | 2016 | 2203 | 0.080 |
Why?
|
Ventricular Function, Left | 1 | 2021 | 3660 | 0.080 |
Why?
|
Intracranial Hemorrhages | 1 | 2014 | 855 | 0.080 |
Why?
|
Polymorphism, Genetic | 1 | 2019 | 4326 | 0.080 |
Why?
|
Electrocardiography | 1 | 2021 | 6441 | 0.080 |
Why?
|
Cardiac Surgical Procedures | 1 | 2023 | 3537 | 0.080 |
Why?
|
Logistic Models | 3 | 2017 | 13404 | 0.080 |
Why?
|
Sepsis | 1 | 2021 | 2593 | 0.070 |
Why?
|
Endothelium, Vascular | 1 | 2018 | 4459 | 0.070 |
Why?
|
Proportional Hazards Models | 4 | 2022 | 12354 | 0.070 |
Why?
|
Prevalence | 3 | 2017 | 15211 | 0.060 |
Why?
|
Genomics | 1 | 2021 | 5714 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 9944 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2020 | 3155 | 0.060 |
Why?
|
Insulin Resistance | 1 | 2018 | 3863 | 0.060 |
Why?
|
Recurrence | 1 | 2016 | 8337 | 0.060 |
Why?
|
Thiazides | 1 | 2023 | 18 | 0.060 |
Why?
|
Insulin | 1 | 2018 | 6584 | 0.060 |
Why?
|
Amlodipine | 1 | 2023 | 83 | 0.060 |
Why?
|
Survival Analysis | 1 | 2016 | 10251 | 0.060 |
Why?
|
Receptors, Angiotensin | 1 | 2023 | 141 | 0.060 |
Why?
|
DNA Methylation | 1 | 2017 | 4286 | 0.050 |
Why?
|
Glycerol | 1 | 2023 | 278 | 0.050 |
Why?
|
Cohort Studies | 2 | 2023 | 40545 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2023 | 11708 | 0.050 |
Why?
|
Massachusetts | 3 | 2021 | 8660 | 0.050 |
Why?
|
ROC Curve | 2 | 2020 | 3527 | 0.050 |
Why?
|
Eicosanoids | 1 | 2022 | 279 | 0.050 |
Why?
|
Neprilysin | 1 | 2023 | 439 | 0.050 |
Why?
|
Glutamine | 1 | 2023 | 579 | 0.040 |
Why?
|
Automation | 1 | 2020 | 584 | 0.040 |
Why?
|
Blood Coagulation | 1 | 2024 | 1127 | 0.040 |
Why?
|
Waist Circumference | 1 | 2022 | 917 | 0.040 |
Why?
|
Systems Biology | 1 | 2021 | 470 | 0.040 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2023 | 1240 | 0.040 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2023 | 923 | 0.040 |
Why?
|
Blotting, Southern | 1 | 2017 | 803 | 0.040 |
Why?
|
Brachial Artery | 1 | 2018 | 369 | 0.040 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2023 | 1516 | 0.040 |
Why?
|
Adult | 5 | 2023 | 213889 | 0.040 |
Why?
|
Ultrasonography, Doppler | 1 | 2018 | 458 | 0.030 |
Why?
|
Nursing Homes | 1 | 2023 | 1036 | 0.030 |
Why?
|
Life Style | 2 | 2018 | 3833 | 0.030 |
Why?
|
Survival Rate | 2 | 2021 | 12786 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15067 | 0.030 |
Why?
|
Hyperlipidemias | 1 | 2019 | 789 | 0.030 |
Why?
|
Hypothyroidism | 1 | 2019 | 659 | 0.030 |
Why?
|
Prospective Studies | 1 | 2019 | 53250 | 0.030 |
Why?
|
Reference Values | 1 | 2021 | 4974 | 0.030 |
Why?
|
Morbidity | 1 | 2019 | 1768 | 0.030 |
Why?
|
Electronic Health Records | 2 | 2020 | 4467 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2017 | 12243 | 0.030 |
Why?
|
Body Height | 1 | 2019 | 1579 | 0.030 |
Why?
|
CpG Islands | 1 | 2017 | 1170 | 0.030 |
Why?
|
Heart Valve Diseases | 1 | 2019 | 1073 | 0.020 |
Why?
|
Phenotype | 2 | 2020 | 16361 | 0.020 |
Why?
|
Creatinine | 1 | 2016 | 1918 | 0.020 |
Why?
|
Cause of Death | 1 | 2021 | 3580 | 0.020 |
Why?
|
Risk Reduction Behavior | 1 | 2017 | 1125 | 0.020 |
Why?
|
Health Care Costs | 1 | 2023 | 3207 | 0.020 |
Why?
|
Health Status | 1 | 2023 | 4031 | 0.020 |
Why?
|
Action Potentials | 1 | 2017 | 1804 | 0.020 |
Why?
|
Peripheral Arterial Disease | 1 | 2019 | 1188 | 0.020 |
Why?
|
Body Weight | 1 | 2019 | 4670 | 0.020 |
Why?
|
Health Surveys | 1 | 2018 | 4036 | 0.020 |
Why?
|
Genetic Loci | 1 | 2017 | 2575 | 0.020 |
Why?
|
Neoplasms | 1 | 2016 | 21675 | 0.020 |
Why?
|
Models, Genetic | 1 | 2017 | 3492 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2018 | 2877 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6539 | 0.020 |
Why?
|
Databases, Factual | 1 | 2020 | 7729 | 0.020 |
Why?
|
Registries | 1 | 2020 | 8090 | 0.020 |
Why?
|
Coronary Disease | 1 | 2019 | 6078 | 0.020 |
Why?
|
Lung | 1 | 2023 | 9858 | 0.020 |
Why?
|
Body Mass Index | 1 | 2022 | 12718 | 0.010 |
Why?
|
Odds Ratio | 1 | 2016 | 9848 | 0.010 |
Why?
|
Blood Pressure | 1 | 2019 | 8551 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2023 | 25609 | 0.010 |
Why?
|
Smoking | 1 | 2019 | 8984 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2018 | 19232 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10259 | 0.010 |
Why?
|
Algorithms | 1 | 2020 | 13869 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 25032 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15526 | 0.010 |
Why?
|
Quality Improvement | 1 | 2014 | 3750 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2017 | 12066 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2014 | 7908 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2017 | 15518 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2016 | 6485 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 17439 | 0.010 |
Why?
|
Animals | 1 | 2021 | 168660 | 0.010 |
Why?
|
Concepts
(172)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(30)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_